>
Organization
MorphoSys AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on MorphoSys AG

... MorphoSys has partnered with I-Mab to support development of anti-C5aR antibody MOR210. The ...
... MorphoSys's Novel Immuno-Oncology Agent MOR210 DGAP-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys ...
... DGAP-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement 2:00pm CET (1:00pm GMT ...
... Study in Rheumatoid Arthritis to be Presented at the ACR Conference DGAP-News: MorphoSys AG / Key word(s): Study results/Conference MorphoSys's Licensing Partner GSK has Reported ...
... Director of EMEA Research, Bloomberg Intelligence, speaks to Simon Moroney, CEO of Morphosys, one of the longest serving and successful CEOs in the industry, to ...
... to its board of directors. Dr. Peters is Chief Development Officer at MorphoSys AG and is among the most experienced translational research and clinical development ...
... Trial (PROTOSTAR) to Evaluate Guselkumab in Pediatric Psoriasis Patients DGAP-News: MorphoSys AG / Key word(s): Study MorphoSys Announces its Licensee Janssen has Initiated ...
... in the biotechnology and healthcare industry and currently serves as CFO of Morphosys AG. "We are delighted to have Mr. Jens Holstein join our Board ...
... Long-Term Patient-Reported Outcomes in Patients with Moderate to Severe Plaque Psoriasis DGAP-News: MorphoSys AG / Key word(s): Study results/Conference MorphoSys Announces That its Licensee Janssen ...
... DGAP-News: MorphoSys AG / Key word(s): Miscellaneous TecDAX segment, to which they have belonged ...
Subscribe now for full coverage on MorphoSys AG
Start My Free Trial